![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](bt2778contents.gif)
Acta Cryst. (2008). E64, m1236 [ doi:10.1107/S1600536808027773 ]
-1,3-bis(4,5-dihydroimidazol-2-yl)benzene-
2N:N']bis[dichloridozinc(II)] N,N'-dimethylformamide disolvateAbstract: The title compound, [Zn2Cl4(C12H14N4)2]·2C3H7NO, is located on a centre of inversion with one half of a complex molecule and one dimethylformamide solvent molecule in the asymmetric unit. The ZnII ion is tetrahedrally coordinated by two organic ligands and two chloride ions. Each organic ligand acts as a bidentate ligand, connecting two ZnII ions, resulting in a dimeric [2:2] metallamacrocyclic structure. Adjacent molecules are further linked by N-H
Cl hydrogen bonds and the solvent is linked to the complex by N-H
O hydrogen bonds.
Online 6 September 2008
Copyright © International Union of Crystallography
IUCr Webmaster